Unknown PHASE1/PHASE2 INTERVENTIONAL NCT00209794

IPTi in Mozambican Infants for Malaria Prevention

The Impact of Intermittent Malaria Treatment Administered Through the EPI Scheme on Malaria Morbidity in Mozambican Children

Sponsor: Hospital Clinic of Barcelona

Conditions Malaria

Interventions Sulfadoxine-Pyrimethamine (Fansidar)

Updated 5 times since 2017 Last updated: Nov 15, 2006 Started: Sep 30, 2002 Completion: Dec 31, 2005

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1/PHASE2 clinical study on Malaria, this trial is ongoing. The trial is conducted by Hospital Clinic of Barcelona and has accumulated 5 data snapshots since 2002. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1/PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1/PHASE2

Status: Unknown Status → Unknown · Phase: PHASE1_PHASE2 → PHASE1/PHASE2
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1_PHASE2
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1_PHASE2
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1_PHASE2

First recorded

Sep 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hospital Clinic of Barcelona

Data source: Hospital Clinic of Barcelona

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Manhiça, Mozambique